Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 6/2011

01-12-2011 | SIN Document

Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group

Authors: A. Ghezzi, R. Carone, G. Del Popolo, M. P. Amato, A. Bertolotto, M. Comola, U. Del Carro, P. Di Benedetto, A. Giannantoni, M. L. Lopes de Carvalho, E. Montanari, F. Patti, A. Protti, S. Rasia, A. Salonia, C. Scandellari, F. Sperli, M. Spinelli, C. Solaro, A. Uccelli, M. Zaffaroni, V. Zipoli, The Multiple Sclerosis Study Group, Italian Society of Neurology

Published in: Neurological Sciences | Issue 6/2011

Login to get access

Abstract

Urinary disorders are uncommon in the initial phases of multiple sclerosis, but increase in frequency as the disease progresses, with a negative impact on quality of life. The goal of this study was to propose a protocol for the diagnosis and treatment of urinary disorders in multiple sclerosis, based on data from the scientific literature and the experience of Italian clinical centres. In particular, the following clinical aspects were considered: what to do with patients with asymptomatic multiple sclerosis; what to do with symptomatic patients; how and when to perform a second-level diagnostic evaluation; and how to treat urinary disorders. A diagnostic–therapeutic algorithm is proposed, that can be applied in Italian clinical centres.
Literature
1.
De Sèze M, Ruffion A, Denys P et al (2007) The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler 13:915–928PubMedCrossRef
2.
Litwiller SE, Frohman EM, Zimmern PE (1999) Multiple sclerosis and the urologist. J Urol 61:743–757
3.
Fowler CJ, Paniker JN, Drake M et al (2009) “A UK consensus on the management of the bladder in multiple sclerosis” J. Neurol Neurosurg Psychiatry 80:470–477
4.
4° Consultazione Internazionale sull’Incontinenza: “Linee Guida sull’incontinenza”—Raccomandazioni ICI 2009—Fondazione Italiana Continenza
5.
Stöhrer M, Blok B, Castro-Diaz D et al (2009) EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol 56:81–88PubMedCrossRef
6.
Di Benedetto P, Delneri C, Biasutti E et al (2008) Vesicourethral dysfunction in multiple sclerosis. Initial assessment based on lower urinary tract symptoms and their pathophysiology. Neurol Sci (Suppl 4):S348–S351
7.
Del Popolo G, Panariello G, Del Corso F et al (2008) Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients. Neurol Sci 29(Suppl 4):S352–S355PubMedCrossRef
8.
Motta R, Lopes de Carvalho ML (2008) Management of bladder dysfunction in multiple sclerosis patients: the nurse’s point of view. Neurol Sci 29:S356–S359PubMedCrossRef
9.
Matthews B (1998) Symptoms and signs of multiple sclerosis. In: Compston A et al (eds) McAlpine multiple sclerosis, Churchill Livingstone, London, pp 144–190
10.
Nortvedt MW, Riise T, Frugård J et al (2007) Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler 13:106–112PubMedCrossRef
11.
Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of International Continence Society. Neurourol Urodyn 21:167–178PubMedCrossRef
12.
Koldewijn EL, Hommes OR, Lemmens WA et al (1995) Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J Urol 154:169–173PubMedCrossRef
13.
Frazer ML, Benson JT, Hashemi CAB et al (2007) Sphincter symptoms as predictors of long-term disability in multiple sclerosis. Arch Neurol 64:1359PubMedCrossRef
14.
Nortvedt MW, Riise T, Myhr KM et al (2001) Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler 7:231–235PubMed
15.
Kirchhof K, Fowler CJ (2000) The value of the Kurtzke Functional Systems Scales in predicting incomplete bladder emptying. Spinal Cord 38:409–413PubMedCrossRef
16.
Bonniaud V, Bryant D, Parratte B, Guyatt G (2008) Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen. J Urol 180:2592–2598PubMedCrossRef
17.
Karsenty G, Denys P, Amarenco G et al (2008) Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol 53:275–287PubMedCrossRef
18.
Kavia RB, De Ridder D, Constantinescu CS (2010) Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Mult Scler 16:1349–1359PubMedCrossRef
19.
Klaskov P et al (1994) BF treatment of bladder dysfunction in MS—a randomized trial. Scan J Urol Nephrol suppl 157:61–65
20.
Vahtera T et al (1997) Pelvic floor rehabilitation is effective in patients with MS. Clin Rehabil 11:211–219PubMedCrossRef
21.
De Ridder D et al (1999) Pelvic Floor rehabilitation in MS. Acta Neurol Belg 99:61–64PubMed
22.
Krivoborodov GG et al (2002) Afferent stimulation of tibial nerve in patients with hyperactive bladder. Urology 5:36–39
23.
Amarenco G et al (2003) Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol 169:2210–2215PubMedCrossRef
24.
McClurg D et al (2006) Comparison of pelvic muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with MS: a randomized pilot study. Neurourol Urodyn 25:337–348PubMedCrossRef
25.
Kabay SC et al (2008) Acute effect of PTNS on neurogenic detrusor overactivity in patients with MS: urodynamic study. Urology 71:641–645PubMedCrossRef
26.
Lopes ML et al (2010) Effectiveness of rehabilitation on urinary disorders in MS. Neurol Sci 31(Suppl.):454
Metadata
Title
Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group
Authors
A. Ghezzi
R. Carone
G. Del Popolo
M. P. Amato
A. Bertolotto
M. Comola
U. Del Carro
P. Di Benedetto
A. Giannantoni
M. L. Lopes de Carvalho
E. Montanari
F. Patti
A. Protti
S. Rasia
A. Salonia
C. Scandellari
F. Sperli
M. Spinelli
C. Solaro
A. Uccelli
M. Zaffaroni
V. Zipoli
The Multiple Sclerosis Study Group, Italian Society of Neurology
Publication date
01-12-2011
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 6/2011
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-011-0794-y

Other articles of this Issue 6/2011

Neurological Sciences 6/2011 Go to the issue

Case Report

Can triptans safely be used for airplane headache?

Brief Communication

Bilateral abducens palsy in a case of cytomegalovirus-associated Guillain–Barré syndrome

Original Article

Comparative fibril formation of analogs corresponding to the (12–24) segment of the β-amyloid peptide

News and Views

Check your vestibular skills by reading about the rotational vertebral artery syndrome

Letter to the Editor

Pontine hemorrhage at a microbleed site in a patient with central pontine myelinolysis

Original Article

Pharmacological and behavioral characterization of the saphenous chronic constriction injury model of neuropathic pain in rats